崔家華

崔家華,男,博士,上海交通大學環境科學與工程學院助理研究員。

基本介紹

  • 中文名:崔家華
  • 畢業院校:上海交通大學
  • 學位/學歷:博士
  • 專業方向:環境科學與工程
  • 任職院校:上海交通大學
人物經歷,研究方向,學術成果,研究成果,榮獲獎項,

人物經歷

2014年6月博士畢業樂漏體雅於上海交通大學藥學院,獲醫學博士學位
同年入選上海交通大學“優秀博士畢業生海外博士後師資儲備項目”,並進入上海交通大學生命科學技術學院生物學博士後流動站進行研究工作。
2015年獲中國博士後科學基金會“香江奔局刪汽學者計畫”項目資助,並於探笑府章虹雄2016年至2018年在香港理工大學套用生物及化學工程系進行套多博士後研究才凳巴工作。灑她府

研究方向

環境污染物的毒理學研究
環境污染物的化學防護

學術成果

Jiahua Cui#, Xu Zhang#, Guang Huang#, Qijiang Zhang, Jinyun Dong, Gege Sun, Qingqing Meng* and Shaoshun Li*. DMAKO-20 as a new multi-target anticancer prodrug activated by the tumor specific CYP1B1 enzyme. Mol. Pharmaceutics, 2019, 16 (1), 409-421.
Jiahua Cui*, Xiaoyang Liu and Larry M. C. Chow. Flavonoids as P-gp inhibitors: a systematic review of SARs. Curr. Med. Chem., 2018, E-pub ahead of print. DOI: 10.2174/0929867325666181001115225.
Jiahua Cui#, Qingqing Meng#, Xu Zhang, Qing Cui, Wen Zhou and Shaoshun Li*. Design and synthesis of new α-naphthoflavones as cytochrome P450 (CYP) 1B1 inhibitors to overcome docetaxel-resistance associated with CYP1B1 overexpression. J. Med. Chem., 2015, 58(8), 3534-3547.
Jiahua Cui, Qing Cui, Qijing Zhang, Shaoshun Li. An efficient multigram synthesis of juglone methyl ether. J. Chem. Res., 2015, 39(9), 553-554.
Jiahua Cui and Shaoshun Li. Inhibitors and prodrugs targeting CYP1: a novel approach in cancer prevention and therapy. Curr. Med. Chem., 2014, 21(5), 519-552.
Jiahua Cui and Shaoshun Li. An efficient synthesis of 5,6-dimethoxy 1- and 2-naphthols via Teuber reaction. J. Chin. Chem. Soc., 2013, 60(9), 1163-1168.
Jiahua Cui and Shaoshun Li. Structure, chemistry and pharmacology of naphthoflavones. Mini-Rev. Med. Chem., 2013, 13(9), 1357-1368.
Jiahua Cui, Dagula Hu, Xu Zhang, Zheng Jing, Jing Ding, Rubing Wang and Shaoshun Li. Design and synthesis of new 7,8-dimethoxy-α-naphthoflavones as CYP1A1 inhibitors. Chin. Chem. Lett., 2013, 24(3), 215-218.
Jiahua Cui and Shaoshun Li. A convenient and efficient synthesis of 2,6-dihydroxynaphthalene. J. Chem. Res., 2012, 36(11), 675-677.
Jiahua Cui, Wen Zhou and Shaoshun Li. A convenient and efficient synthesis of 2-acetyl-5,8-dimethoxy-1,4-naphthoquinone. J. Chem. Res., 2012, 36(5), 264-265.
Yao-yao Yang#, Hui-qiong He#, Jia-hua Cui#, Yun-juan Nie, Ya-xian Wu, Rui Wang, Gang Wang, Jun-Nian Zheng, Richard D. Ye, Qiong Wu, Shao-shun Li, Feng Qian. Shikonin derivative DMAKO-05 inhibits Akt signal activation and melanoma proliferation. Chem. Biol. Drug Des., 2016, 87(6), 895-904. (#: Co-first author)
Jinyun Dong, Zengtao Wang, Qingqing Meng, Qijing Zhang, Guang Huang, Jiahua Cui*, Shaoshun Li*. Development of 2-arylbenzo[h]quinolone analogs as selective CYP1B1 inhibitors. RSC Advances, 2018, 8(27), 15009-15020. (*: Correspondent)Jinyun Dong, Qijing Zhang, Qingqing Meng, Zengtao Wang, Shaoshun Li*, Jiahua Cui*. Chemistry and Pharmacology of Thioflavones. Mini-Rev. Med. Chem., 2018, 18(20), 1714 – 1732.
Qijing Zhang, Jinyun Dong, Qing Cui, Shaoshun Li*; Jiahua Cui*. Synthesis of 4,8-dimethoxy-1-naphthol via an acetyl migration. Synth. Commun., 2017, 47(6), 536-540.
Xu Zhang, Jiahua Cui, Qingqing Meng, Shaoshun Li, Wen Zhou and Sui Xiao. Advance in Anti-tumor Mechanisms of Shikonin, Alkannin and Their Derivatives. Mini-Rev. Med. Chem., 2018, 18(2), 164-172.
Qingqing Meng, Zengtao Wang, Jiahua Cui, Qing Cui, Jinyun Dong, Qijing Zhang, Shaoshun Li. Design, Synthesis, and Biological Evaluation of Cytochrome P450 1B1 Targeted Molecular Imaging Probes for Colorectal Tumor Detection. J. Med. Chem., 2018, 61(23), 10901–10909.
Qijing Zhang, Jinyun Dong, Jiahua Cui, Guang Huang, Qingqing Meng, Shaoshun Li. Cytotoxicity of Synthesized 1,4-Naphthoquinone Oxime Derivatives on Selected Human Cancer Cell Lines. Chem. Pharm. Bull., 2018, 66(6), 612-619.
Xu Zhang, Jiahua Cui, Wen Zhou, Shaoshun Li. Design, synthesis and anticancer activity of shikonin and alkannin derivatives with different substituents on the naphthazarin scaffold. Chem. Res. Chinese U., 2015, 31(3), 394-400.
Rubing Wang, Wen Zhou, Qingqing Meng, Xu Zhang, Jing Ding, Yan Xu, Hualong Song, Kai Yang, Jiahua Cui, Shaoshun Li. Design, synthesis and biological evaluation of shikonin and alkannin derivatives as potential anticancer agents via a prodrug approach. ChemMedChem, 2014, 9(12), 2798-2808.
Rubing Wang, Hui Guo, Jiahua Cui and Shaoshun Li. A novel and efficient total synthesis of shikonin. Tetrahedron. Lett., 2012, 53, 3977-3980.

研究成果

主持國家自然科學基金青年基金項目、“香江學者計畫”項目、中國博士後科學基金面上項目、上海交通大學“優秀博士畢業生海外博士後師資儲備項目”等。在J. Med. Chem., Mol. Pharmaceutics, Curr. Med. Chem.等期刊發表SCI論文20多篇,其中第一作者、通訊作者論文13篇。
國家自然科學基金青年基金項目,21602132,α-萘黃酮類CYP1B1酶抑制劑的設計、合成及其逆轉紫杉烷類抗腫瘤藥物耐藥的機制研究,2017/01-2019/12,在研,主持。
中國博士後科學基金會“香江學者計畫”項目,XJ2015032,腫瘤幹細胞的抗藥性機理及小分子逆轉耐藥研究,在研,主持。
中國博士後基金面上項目,2014M561479,以CYP1B1酶為靶點的近紅外螢光探針的設計合成及生物學基礎研究,2015/01-2018/12,已結題、主持。
國家自然科學基金面上項目,81673281,由腫瘤細胞特異性表達的CYP1酶活化的抗腫瘤前藥萘醌肟衍生物的設計合成,活性評價及代謝研究,2017/01-2020/12,在研,參加。
國家自然科學基金面上項目,81373274,以紫草素及二甲基紫草素肟衍生物為小分子探針,探索其抗腫瘤作用的新靶點和新機制,2014/01-2017/12,已結題,參加
上海市科委生物醫藥領域科技支撐項目,15431900700,逆轉多西紫杉醇耐藥的新藥候選物NF-60的成藥性研究,2015/09-2018/06,已結題,參加。
李紹順, 崔家華, 孟青青。水溶性α-萘黃酮醇衍生物及其製備方法、用途。國際發明專利申請號:PCT CN2014/091234。
李紹順, 崔家華, 張旭。α-萘黃酮衍生物及其製備方法、用途。中國發明專利授權專利號:ZL 201210475989。
李紹順,崔慶,孟青青,崔家華。水溶性α-萘黃酮醇衍生物及其製備方法、用途。中國發明專利授權專利號:ZL 201410228733。

榮獲獎項

2016年03月 中國博士後管委會辦公室-香港學者協會 “香江學者”獎
2014年06月 上海交通大學“優秀博士畢業生海外博士後師資儲備項目”
2013年12月 博士研究生國家獎學金
2012年10月 第十八屆上海高校學生創造發明“科技創業杯”二等獎
Jiahua Cui and Shaoshun Li. Structure, chemistry and pharmacology of naphthoflavones. Mini-Rev. Med. Chem., 2013, 13(9), 1357-1368.
Jiahua Cui, Dagula Hu, Xu Zhang, Zheng Jing, Jing Ding, Rubing Wang and Shaoshun Li. Design and synthesis of new 7,8-dimethoxy-α-naphthoflavones as CYP1A1 inhibitors. Chin. Chem. Lett., 2013, 24(3), 215-218.
Jiahua Cui and Shaoshun Li. A convenient and efficient synthesis of 2,6-dihydroxynaphthalene. J. Chem. Res., 2012, 36(11), 675-677.
Jiahua Cui, Wen Zhou and Shaoshun Li. A convenient and efficient synthesis of 2-acetyl-5,8-dimethoxy-1,4-naphthoquinone. J. Chem. Res., 2012, 36(5), 264-265.
Yao-yao Yang#, Hui-qiong He#, Jia-hua Cui#, Yun-juan Nie, Ya-xian Wu, Rui Wang, Gang Wang, Jun-Nian Zheng, Richard D. Ye, Qiong Wu, Shao-shun Li, Feng Qian. Shikonin derivative DMAKO-05 inhibits Akt signal activation and melanoma proliferation. Chem. Biol. Drug Des., 2016, 87(6), 895-904. (#: Co-first author)
Jinyun Dong, Zengtao Wang, Qingqing Meng, Qijing Zhang, Guang Huang, Jiahua Cui*, Shaoshun Li*. Development of 2-arylbenzo[h]quinolone analogs as selective CYP1B1 inhibitors. RSC Advances, 2018, 8(27), 15009-15020. (*: Correspondent)Jinyun Dong, Qijing Zhang, Qingqing Meng, Zengtao Wang, Shaoshun Li*, Jiahua Cui*. Chemistry and Pharmacology of Thioflavones. Mini-Rev. Med. Chem., 2018, 18(20), 1714 – 1732.
Qijing Zhang, Jinyun Dong, Qing Cui, Shaoshun Li*; Jiahua Cui*. Synthesis of 4,8-dimethoxy-1-naphthol via an acetyl migration. Synth. Commun., 2017, 47(6), 536-540.
Xu Zhang, Jiahua Cui, Qingqing Meng, Shaoshun Li, Wen Zhou and Sui Xiao. Advance in Anti-tumor Mechanisms of Shikonin, Alkannin and Their Derivatives. Mini-Rev. Med. Chem., 2018, 18(2), 164-172.
Qingqing Meng, Zengtao Wang, Jiahua Cui, Qing Cui, Jinyun Dong, Qijing Zhang, Shaoshun Li. Design, Synthesis, and Biological Evaluation of Cytochrome P450 1B1 Targeted Molecular Imaging Probes for Colorectal Tumor Detection. J. Med. Chem., 2018, 61(23), 10901–10909.
Qijing Zhang, Jinyun Dong, Jiahua Cui, Guang Huang, Qingqing Meng, Shaoshun Li. Cytotoxicity of Synthesized 1,4-Naphthoquinone Oxime Derivatives on Selected Human Cancer Cell Lines. Chem. Pharm. Bull., 2018, 66(6), 612-619.
Xu Zhang, Jiahua Cui, Wen Zhou, Shaoshun Li. Design, synthesis and anticancer activity of shikonin and alkannin derivatives with different substituents on the naphthazarin scaffold. Chem. Res. Chinese U., 2015, 31(3), 394-400.
Rubing Wang, Wen Zhou, Qingqing Meng, Xu Zhang, Jing Ding, Yan Xu, Hualong Song, Kai Yang, Jiahua Cui, Shaoshun Li. Design, synthesis and biological evaluation of shikonin and alkannin derivatives as potential anticancer agents via a prodrug approach. ChemMedChem, 2014, 9(12), 2798-2808.
Rubing Wang, Hui Guo, Jiahua Cui and Shaoshun Li. A novel and efficient total synthesis of shikonin. Tetrahedron. Lett., 2012, 53, 3977-3980.

研究成果

主持國家自然科學基金青年基金項目、“香江學者計畫”項目、中國博士後科學基金面上項目、上海交通大學“優秀博士畢業生海外博士後師資儲備項目”等。在J. Med. Chem., Mol. Pharmaceutics, Curr. Med. Chem.等期刊發表SCI論文20多篇,其中第一作者、通訊作者論文13篇。
國家自然科學基金青年基金項目,21602132,α-萘黃酮類CYP1B1酶抑制劑的設計、合成及其逆轉紫杉烷類抗腫瘤藥物耐藥的機制研究,2017/01-2019/12,在研,主持。
中國博士後科學基金會“香江學者計畫”項目,XJ2015032,腫瘤幹細胞的抗藥性機理及小分子逆轉耐藥研究,在研,主持。
中國博士後基金面上項目,2014M561479,以CYP1B1酶為靶點的近紅外螢光探針的設計合成及生物學基礎研究,2015/01-2018/12,已結題、主持。
國家自然科學基金面上項目,81673281,由腫瘤細胞特異性表達的CYP1酶活化的抗腫瘤前藥萘醌肟衍生物的設計合成,活性評價及代謝研究,2017/01-2020/12,在研,參加。
國家自然科學基金面上項目,81373274,以紫草素及二甲基紫草素肟衍生物為小分子探針,探索其抗腫瘤作用的新靶點和新機制,2014/01-2017/12,已結題,參加
上海市科委生物醫藥領域科技支撐項目,15431900700,逆轉多西紫杉醇耐藥的新藥候選物NF-60的成藥性研究,2015/09-2018/06,已結題,參加。
李紹順, 崔家華, 孟青青。水溶性α-萘黃酮醇衍生物及其製備方法、用途。國際發明專利申請號:PCT CN2014/091234。
李紹順, 崔家華, 張旭。α-萘黃酮衍生物及其製備方法、用途。中國發明專利授權專利號:ZL 201210475989。
李紹順,崔慶,孟青青,崔家華。水溶性α-萘黃酮醇衍生物及其製備方法、用途。中國發明專利授權專利號:ZL 201410228733。

榮獲獎項

2016年03月 中國博士後管委會辦公室-香港學者協會 “香江學者”獎
2014年06月 上海交通大學“優秀博士畢業生海外博士後師資儲備項目”
2013年12月 博士研究生國家獎學金
2012年10月 第十八屆上海高校學生創造發明“科技創業杯”二等獎

相關詞條

熱門詞條

聯絡我們